Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Preliminary findings from a single-arm, prospective phase II trial (RIFLE)

被引:0
|
作者
Chen, Y. [1 ]
Wang, K. [1 ]
Zhiyuan, Z. [2 ]
Zhang, H. [1 ]
Yang, W. [1 ]
Wu, R. [1 ]
Zhou, M. [1 ]
Zhang, Z. [1 ]
Xia, F. [1 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Therapy, Shanghai, Peoples R China
关键词
D O I
10.1016/j.annonc.2023.09.1828
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
638P
引用
收藏
页码:S451 / S451
页数:1
相关论文
共 50 条
  • [41] Stereotactic focal radiotherapy as an alternative treatment for low-risk prostate cancer: Results of a single-arm monocenter Phase-II trial
    Nguyen, Paul V.
    Donneaux, Bertrand
    Louis, Celine
    Bodgal, Zsuzsa
    Philippi, Sven
    Biver, Sylvie
    Frederick, Berangere
    Harze, Ludovic
    Lasar, Yves
    Vogin, Guillaume
    Nickers, Philippe
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Jinsong Yang
    Ai Huang
    Kunyu Yang
    Ke Jiang
    BMC Cancer, 23
  • [43] Efficacy and safety of tislelizumab plus anlotinib in the treatment of cervical cancer resistant to standard therapy: A prospective, single-arm, open labelled phase II clinical trial
    Zheng, M.
    Zhou, Y.
    Zhou, J.
    Jiang, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S806 - S806
  • [44] Neoadjuvant tislelizumab combined with lenvatinib plus transcatheter arterial chemoembolization in resectable hepatocellular carcinoma with high-risk of recurrence: A prospective, single-arm, phase II trial
    Chen, Zhiyu
    Zhang, Leida
    Zhang, Hui
    Gong, Yi
    Feng, Kai
    Ma, Kuansheng
    Bi, Huaqiang
    Xia, Feng
    Dai, Haisu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Kazuhisa Yamaguchi
    Hiroya Taniguchi
    Azusa Komori
    Yukiya Narita
    Sohei Nitta
    Motoo Nomura
    Shigenori Kadowaki
    Daisuke Takahari
    Takashi Ura
    Masashi Andoh
    Kei Muro
    Keita Mori
    Yoshinori Igarashi
    BMC Cancer, 15
  • [46] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Yamaguchi, Kazuhisa
    Taniguchi, Hiroya
    Komori, Azusa
    Narita, Yukiya
    Nitta, Sohei
    Nomura, Motoo
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    Mori, Keita
    Igarashi, Yoshinori
    BMC CANCER, 2015, 15
  • [47] TACE combined with tislelizumab and TKI as a conversion therapy in initial unresectable hepatocellular carcinoma (uHCC): A prospective single-arm phase II clinical study
    Liu, S.
    Lin, S.
    Luo, H.
    Luo, J.
    Mo, W.
    Zhong, J-H.
    ANNALS OF ONCOLOGY, 2024, 35 : S78 - S79
  • [48] Neoadjuvant tislelizumab plus chemotherapy followed by salvage surgery and adjuvant tislelizumab for recurrent head and neck squamous cell carcinoma after radiotherapy: A single-arm, phase II trial
    Wu, Wenjie
    Wang, Lin
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial
    Wan, Juefeng
    Wu, Ruiyan
    Fu, Miaomiao
    Shen, Lijun
    Zhang, Hui
    Wang, Yan
    Wang, Yaqi
    Zhou, Shujuan
    Chen, Yajie
    Xia, Fan
    Zhang, Zhen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial
    Wismans, Leonoor, V
    Hendriks, Tessa E.
    Suurmeijer, J. Annelie
    Nuyttens, Joost J.
    Bruynzeel, Anna M.
    Intven, Martijn P.
    van Driel, Lydi M.
    Haen, Roel
    de Wilde, Roeland F.
    Koerkamp, Bas Groot
    Busch, Olivier R.
    Stoker, Jaap
    Verheij, Joanne
    Farina, Arantza
    de Boer, Onno J.
    Doukas, Michail
    de Hingh, Ignace H.
    Lips, Daan J.
    van der Harst, Erwin
    van Tienhoven, Geertjan
    van Eijck, Casper H.
    Besselink, Marc G.
    Dutch Pancreatic Canc Grp, Annalisa
    BJS-BRITISH JOURNAL OF SURGERY, 2025, 112 (02):